FDA applicant
Accriva Diagnostics, Inc.
FDA records 3 decisions for Accriva Diagnostics, Inc. (San Diego, CA) from 2019 to 2023: 3 510(k) clearances. Most are in product codes JPA (System, Multipurpose For In Vitro Coagulation…) and FMK (Single Use Only Blood Lancet With An Integral…). Its devices cite 7 predicates, 1 of them its own earlier devices. 1 recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Accriva Diagnostics, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2023
2026 so far, outlined.
Recalls per year
1in 2026
Class I Class II/III not classified
Planning a device like Accriva Diagnostics, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report